Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum
Clinical trial NCT03308357 · UNKNOWN
Trial details
- NCT number
- NCT03308357
- Sponsor
- The Alfred
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-10-01
- Primary completion
- 2018-03-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.